Atlas Trials

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

Clinical trial NCT02533258 · COMPLETED

Trial details

NCT number
NCT02533258
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Renal Cell Carcinoma
Start date
2015-12-02
Primary completion
2016-05-12
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.